Currently Viewing:
Newsroom
Currently Reading
CDC Report Looks at Nonadherence to HIV Medications Due to Cost
December 28, 2019 – Alison Rodriguez
US Unveils Proposed Rules to Allow Some Canadian Drug Imports
December 18, 2019 – Allison Inserro
Treating HIV Comorbidities in the Fight to End the Epidemic
December 16, 2019 – Maggie L. Shaw
People With HIV/AIDS at Greater Risk for Chronic Illnesses, Study Finds
December 15, 2019 – Alison Rodriguez
Biomarkers Needed for HIV-Associated Neurocognitive Disorder
December 08, 2019 – Alison Rodriguez
What We're Reading: Gilead Patent Extension Controversy; Teen Tobacco Use; Postpartum Depression Disparities
December 06, 2019 – AJMC Staff
Initiative Launches to Increase Access to PrEP in the Fight to End HIV
December 03, 2019 – Maggie L. Shaw
Medical Monitoring Project Provides National Population Based Data on Patients With HIV
November 29, 2019 – Alison Rodriguez
Canadian Study Shows Connection Between HIV, Early-Onset Menopause in Women
November 24, 2019 – Maggie L. Shaw

CDC Report Looks at Nonadherence to HIV Medications Due to Cost

Alison Rodriguez
The report suggests that removing barriers to coverage, as well as reducing medication costs for people with private insurance, would help decrease cost-related nonadherence to HIV therapies.
Nonadherence to prescribed medication among HIV patients may be associated with unmet need for the Ryan White AIDS Drug Assistance Program (ADAP), not having Medicaid, having private insurance, lower HIV medical care engagement, and lower viral suppression, according to the CDC’s recent Morbidity and Mortality Weekly Report.

The report included data from the CDC’s Medical Monitoring Project, which analyzed cross-sectional, nationally representative, medical care, and clinical outcomes of adults with HIV. According to this data, during 2016-2017, 14% of people with HIV used a prescription drug cost-saving strategy for any prescribed medication and 7% had cost saving-related nonadherence.

“Nonadherence due to prescription drug costs was associated with reporting an unmet need for medications from the Ryan White AIDS Drug Assistance Program (ADAP), not having Medicaid coverage, and having private insurance. Persons who were nonadherent because of cost concerns were more likely to have visited an emergency department, have been hospitalized, and not be virally suppressed,” noted the authors. “Reducing barriers to ADAP and Medicaid coverage, in addition to reducing medication costs for persons with private insurance, might help to decrease nonadherence due to cost concerns and, thus contribute to improved viral suppression rates and other health outcomes among persons with HIV infection.”

The Medical Monitoring Project collected data through face-to-face or telephone interviews and medical record abstraction of those with HIV infection during June 2016 to May 2017. Among the adults with HIV who used cost-saving strategies and reported cost-saving nonadherence: 4% took less medicine, 6% delayed a prescription, 9% asked a doctor for a lower-cost medicine, 1% bought drugs from another country, and 2% used alternative medicine.

Based on the data, cost-saving nonadherence was not related to age, race/ethnicity, gender, homelessness, or time since HIV diagnosis. Instead, the data suggested that nonadherence was associated with household income as well as disability.

“Among those with health insurance, cost saving–related nonadherence was more likely among persons with private insurance (8%) than among those who did not have private insurance (6%) and was less likely among those with Medicaid (5%) than among those who did not have Medicaid (8%),” the report said. “Persons who had an unmet need for medications from ADAP were approximately five times as likely to be nonadherent because of cost (32%) than were those who received ADAP.”

The report suggests that removing barriers to ADAP and Medicaid coverage, as well as reducing medication costs for people with private insurance, would help decrease cost-related nonadherence. In turn, this could help improve health outcomes for persons living with HIV infection and reduce HIV transmission.

Related Articles

In the Race to Treat HIV, Are Patients Newly on Medication Adherent?
Adherence to Antiretroviral Therapy and Healthcare Utilization Trends in Commercially Insured Patients With HIV
Medical Monitoring Project Provides National Population Based Data on Patients With HIV
Initiative Launches to Increase Access to PrEP in the Fight to End HIV
People With HIV/AIDS at Greater Risk for Chronic Illnesses, Study Finds
 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up